Scinvivo develops imaging technology that specializes in optical biopsy for bladder cancer diagnostics.
Scinvivo has raised $5.1M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in February 2024.
Scinvivo's investors include Innovatiefonds Noord-Holland, NLC, Netherlands Enterprise Agency, Santec Corporation.
Scinvivo is headquartered in Amsterdam, The Netherlands.
Scinvivo develops imaging technology that specializes in optical biopsy for bladder cancer diagnostics.
Scinvivo is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Scinvivo — Funding & Investors." VCBacked, February 21, 2024, https://www.vcbacked.co/company/scinvivo. Accessed August 14, 2026.
VCBacked. (2024). Scinvivo — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/scinvivo
{{cite web |title=Scinvivo — Funding & Investors |url=https://www.vcbacked.co/company/scinvivo |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated